Source: OKLAHOMA STATE UNIVERSITY submitted to NRP
ANALYSIS OF BOVINE HERPES VIRUS 1 LATENCY AND REACTIVATION FROM LATENCY
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1032059
Grant No.
2024-67015-42257
Cumulative Award Amt.
$650,000.00
Proposal No.
2023-07864
Multistate No.
(N/A)
Project Start Date
Jul 1, 2024
Project End Date
Jun 30, 2028
Grant Year
2024
Program Code
[A1221]- Animal Health and Production and Animal Products: Animal Health and Disease
Recipient Organization
OKLAHOMA STATE UNIVERSITY
(N/A)
STILLWATER,OK 74078
Performing Department
(N/A)
Non Technical Summary
Beef and Dairy cattle are important commodities in the United States. During viral growth, BoHV-1 spreads to sensory neurons in the peripheral nervous system and certain cells in the pharyngeal tonsil where the virus establishes and maintains a life-long latent infection. During latency, BoHV-1 does not grow but it lingers in the latently infected cells. Stress, because of dramatic weather changes and shipping cattle long distances can trigger BoHV-1 to grow in latently infected calves (reactivate from latency). Bovine alpha-herpesvirus 1 (BoHV-1) infection of cattle can cause severe nasal congestion, swelling of the upper respiratory tract, temporary immune suppression, and abortions. BoHV-1 is also a cofactor of bovine respiratory disease (BRD), the most important disease in cattle. BRD can lead to life-threatening lung infections, including pneumonia. The goal of this grant is to identify cellular and BoHV-1 genes that induce reactivation from latency in the peripheral nervous system and pharyngeal tonsil. Understanding how reactivation occurs will allow us to develop superior strategies for vaccine viruses that do not respond to stress and reactivate from latency. This will reduce the spread of BoHV-1 and reduce the incidence of BRD.
Animal Health Component
10%
Research Effort Categories
Basic
80%
Applied
10%
Developmental
10%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31133101101100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3310 - Beef cattle, live animal;

Field Of Science
1101 - Virology;
Goals / Objectives
The goals for this research are summarized in the three Objectives of the grant. These Objectives are summarized below.Objective 1: Analysis of PT cells that harbor viral DNA during latency. Sorting pharyngeal tonsil (PT) single cell suspensions revealed cytokeratin 18+ cells was enriched for bovine alphaherpesvirus 1 (BoHV-1) DNA in latently infected calves. Cytokeratin 18 is expressed on Microfold cells (M-cells), certain epithelial cells, or macrophage like cells. Thus, we hypothesize cytokeratin 18+ PT cells harbor BoHV-1 DNA during latency and support reactivation from latency. Single cell transcriptomic studies of cytokeratin 18+ PT cells will identify cell type(s) harboring viral DNA and differentially expressed cellular genes during reactivation from latency. Objective 2: Analysis of recombinant viruses containing TATA box mutations in the BoHV-1 infected cell protein 0 (bICP0) early promoter or immediate early transcription unit 1 (IEtu1) promoter. The hypothesis of this objective is bICP0 and bICP4 expression trigger reactivation from latency in trigeminal ganglia (TG) and PT. To test this hypothesis, BoHV-1 virus mutants with TATA box mutations in the bICP0 early (E) promoter or IEtu1 promoter will be examined for replication in primary bovine cells and calves.Objective 3. Analysis of cellular transcription factors that cooperate with GR to activate viral gene expression and mediate reactivation from latency. The hypothesis of this objective is glucocorticoid receptor (GR) and the specificity pprotein 1 (Sp1) transcription facotr play crucial roles during viral replication and reactivation from latency in PT and TG. To test this hypothesis, we will examine how GR and Sp1 cooperatively transactivate IEtu1 and bICP0 E promoters, and whether GR stably interacts with Sp1. We will also determine whether certain transcription factors occupy the IEtu1 and bICP0 E promoters during early stages of reactivation of latency.Completing the studies described in these three objectives will provide new insight into the mechanism by which reactivation from latency is triggered in PT and TG. These studies are important because BoHV-1, including all modified live vaccines (MLVs) used in the USA, can reactivate from latency from latency following stressful stimuli, which increases the incidence of bovine respiratory disease(BRD) or abortions.
Project Methods
Objective 1: Analysis of pharyngeal tonsil (PT) cells that harbor viral DNA during latency. To identify cells in PT that are latently infected, we will sort cells and then test each cell type for BoHV-1 DNA. These cells will be explanted and treated with dexamethasone to determine whether BoHv-1 can reactivate from these cells (Objective 1A). For Objective 1B, PT cells that harbor viral DNA, since cell RNA sequencing will be performed to identify viral and cellular genes that are differentially expressed in latently infected cells relative to explant-induced reactivation.Objective 2: Analysis of recombinant viruses containing TATA box mutations in the BoHV-1 infected cell proteins 0 (bICP0) early promoter or IEtu1 promoter. We will test whether mutant viruses replicate as efficiently in cultured cells and in calves. Additional studies will compare the growth properties of the respective mutant viruses to wild-type BoHV-1 and whether they can reactivate from latency in calves.4.3A. Objective 3. Analysis of cellular transcription factors that cooperate with GR to activate viral gene expression and mediate reactivation from latency. Luciferase reporter plasmids containing the bICP0 E promoter and IEtu1 promoter will be utilized to test whether the glucocorticoid receptor and specificity proteins 1 (Sp1) or the Sp3 transcription factor will cooperate with to activate these promoters. Mutagenesis of consensus binding sites for Sp1 and Sp3 will be generated to test how this affects promoter activity. Finally, chromatin immunoprecipitation (ChIP) studies will test whether GR, Sp1, Sp3, and Krüppel like factor 4 (KLF4) or KLF15 occupy the bICP0 E promoter and IEtu1 promoter in transient transfection studies. Finally, ChIP studies be performed using TG from latently infected calves or latently infected calves treated with dexamethasone to trigger reactivation from latency to test whether the cellular transcription factors occupy the bICP0 E promoter or IEtut1 promoter.

Progress 07/01/24 to 06/30/25

Outputs
Target Audience:Cattle are essential food animals and are also raised to produce milk in the United States. Bovine alpha-herpesvirus 1 (BoHV-1) continues to be a signficant problem in dairy and beef cattle. BoHV-1 infects cattle via the ocular, nasal, and/or oral cavity. Sexual transmission of the virus can also occur. Viral growth leads to cell destruction and inflammation in the ocular and nasal cavity, which can trigger secondary bacterial infections and life-threatening pneumonia. Infection also causes fever and short-term immune suppression. As a result of these clinical symptoms, infected animals do not eat or drink very much, which costs the producer money and complicates recovery from infection. BoHV-1 is also an important cofactor of bovine respiratory disease (BRD), the most important disease in cattle. Finally, it is well established that BoHV-1 can induce abortions, in part because the virus gains access to the fetus and replicates to high levels. The focus of this grant is to compare the ability of BoHV-1 to establish, maintain, and reactivate from latency in pharyngeal tonsil relative to sensory neurons in trigeminal ganglia. We will also examine the mechanism by which stress interrupts latency and leads to virus growth and viral transmission; this is referred to as reactivation from latency. A recent publication found that cellular transcription factors, including glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3 cooperatively activates the infected protein 0 (ICP0) early promoter that is a key viral promoter that mediates reactivation from latency. Ongoing studies will identify cell types in pharyngeal tonsil that harbor BoHV-1 during latency and whether these cell populations support viral reactivation from latency. Compelling preliminary studies revealed dendritic cells, micro-fold cells, and natural killer cells contain viral DNA whenthese cells are in the pharyngeal tonsil. Completion of these studies will provide new insight into how reactivation from latency occurs in the pharyngeal tonsil. Understanding these complex viral-host interactions are important because they will provide new strategies designed to developnew therapeutic strategies designed to reduce the incidence of BoHV-1 reactivation from latency. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?A graduate student,Sankha Hewawasam, was first author of the Virus paper published in 2025. These studies are a crucial part of his dissertation. Dr. El-Mayet, a coauthor on the Virus paper, also contributed to these studies. How have the results been disseminated to communities of interest?I talked aobut these studies at CRWAD in January 2025. Furthermore, a paper published in Viruses (https://doi.org/10.3390/v17020229) was part of the studies proposed in this grant. What do you plan to do during the next reporting period to accomplish the goals?Objective 1: Analysis of PT cells that harbor viralDNA during latency.Transcriptomic studies focused on identifying cellular signaling pathways that are differentially expressed during reactivation from latency will be identified. Furthermore, we will test whether viral gene exression during reactivation inDC, Micro-fold cells andNKcells is the same or if their are cell-type specific changes in viral gene expression during reactivation from latency. A manuscript describing these studies will be submitted to an appropriate peer-reviewed journal, J of Virology or PLOS Pathogens. Objective 2: Analysis of recombinant viruses containing TATA box mutations in the bICP0 early promoter or IEtu1 promoter. This bICP0 E TATA box mutant virus wil be repeated and if the results are consistent a manuscript will be submitted. Objective 3. Analysis of cellular transcription factors that cooperate with GR to activate viral gene expression and mediate reactivation from latency.We will complete studies demonstrating GR occupies the IEtu1 and bICP0 E promoters when latently infected calves are treated with dexamethasone for 3 hours. Additional studies will confirm that the histone 3 marker associated with activate chromatin, H3K9 acetylation, also occupiesthese crucial viral promoters during reactivation but not during latency. Finally, we will confirm histone 3 trimethylated at lysine 9, a heterochromatin marker, occupied these viral promoters in TG of latently ifnected calves. A manuscript will be submitted to J Virology describing these studies.

Impacts
What was accomplished under these goals? Objective 1: Analysis of PT cells that harbor viral DNA during latency. Tigeminal ganglia and pahryngeal tonsils latently infected calves and latently calves treated with dexamethasone (DEX) were recently collected. Cell sorting of pharyngeal single cell suspensions were prepared. BoHV-1 DNA was readily detected indendrtitic cells (DC), Micro-fold cells and Natural Killer (NK) cells.Conversely, B and T-cells did not contain detectable levels of viral DNA. Single cell transcriptomic analysis will be performed on DC, Micro-fold cells, and NK cells is in the process to compareviral and cellular gene expression during reactivation from latency. Objective 2: Analysis of recombinant viruses containing TATA box mutations in the bICP0 early promoter or IEtu1 promoter. The hypothesis of this objective is bICP0 and bICP4 expression trigger reactivation from latency in TG and PT. To test this hypothesis, BoHV-1 virus mutants with TATA box mutations in the bICP0 E promoter or IEtu1 promoter will be examined for replication in primary bovine cells and calves. An intial study demonstrated that the bICP0?TATA box mutant grows less efficently than wild-type BoHV-1 and calves infected with the mutant did not exhibit clinical disease. Furthermore, low levels of reactivation occurred in thebICP0?TATA box mutant versus wild-type virus. Objective 3. Analysis of cellular transcription factors that cooperate with GR to activate viral gene expression and mediate reactivation from latency. The hypothesis of this objective is GR and Sp1 play crucial roles during viral replication and reactivation from latency in PT and TG. To test this hypothesis, we will examine how GR and Sp1 cooperatively transactivate IEtu1 and bICP0 E promoters, and whether GR stably interacts with Sp1. We will also determine whether certain transcription factors occupy the IEtu1 and bICP0 E promoters during early stages of reactivation of latency. A manuscript was recently published that demonstrated GR and Sp1 or Sp3 cooperatively transactivates the BoHV-1 bICP0 and immediate early transcirption unit 1 (IEtu1) promtoers. As denoted above, this paper was published in 2025 in Viruses. Additional studies revealed that the glucocorticoid receptor (GR) occupies thebICP0 and immediate early transcirption unit 1 (IEtu1) promtoers during early stages or reactrivation from latency. Notably, it was also clear that during latency these promoters are silent becuase they are occupied by heterochromatin. When DEX was added to calves to initiate reactivation from latency, the silent heterochromatin was remodeld by GR so transcription could occur. These two viral promtoers drive expression of the two most important viral transcriptional regulators, bICP0 and bICP4.

Publications

  • Type: Peer Reviewed Journal Articles Status: Published Year Published: 2025 Citation: Hewawasam SG, F.S. El-Mayet, and C. Jones. 2025. Glucocorticoid receptor (GR) and specificity protein 1 (Sp1) or Sp3 transactivate the bovine herpesvirus 1 (BoHV-1) infected cell protein 0 early promoter. Viruses 17(2), 229.